AirAvant Medical's Bongo Rx is clinically proven to treat symptoms of mild to moderate Obstructive Sleep Apnea (OSA), including loud snoring, caused by blocked air passages
Sleep Apnea Therapy from Home. (Credit: PR Newswire/ AirAvant Medical)
AirAvant Medical developers of the FDA-Cleared clinically proven Bongo Rx CPAP alternative announces a new telemedicine option with iSleep Physicians Group to help patients get a Telehealth prescription, now $35 for the Bongo Rx.
AirAvant Medical’s Bongo Rx is clinically proven to treat symptoms of mild to moderate Obstructive Sleep Apnea (OSA), including loud snoring, caused by blocked air passages. Its simple silicone nasal “pillows,” in contrast to the bulky CPAP machines and masks usually used, are a game-changer in the $3.7 billion global OSA devices market.
Obstructive sleep apnea results when the sleeper’s air passage is blocked. This causes snoring and frequently interrupted sleep, which in turn leads to daytime drowsiness. Left untreated, OSA can contribute to life-threatening conditions including heart disease, stroke, hypertension, diabetes and even dementia.
“We are delighted to partner with AirAvant Medical to help patients access Bongo RX via tele-health. It is a great solution for the tremendous number of patients with mild to moderate obstructive sleep apnea, of which we know many have struggled with CPAP or other treatment options. It’s wonderful to have another solution readily available to be able to treat this condition and prevent the significant medical consequences that can result from it!” says Dr. Haramandeep Singh, M.D., D.ABPN of iSleep Physicians Group
“Obstructive sleep apnea is one of the leading causes of heart disease, stroke and Type 2 diabetes, among other co-morbidities,” continues Dr. Singh. “We’re proud to offer a convenient, easy to use solution for sufferers of this debilitating condition and the loved ones who suffer with them.”
Source: Company Press Release